Skip to content

Clinical trials

Phase 3 Liver Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 3 Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20021
20041
20053
20064
20075
20085
20094
20105
20112
20123
20133
20142
20157
20161
20173
20182
20193
20202
20211
20221
20232
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Unknown status13
Terminated7
Active, not recruiting5
Recruiting4
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University6
Guangxi Medical University5
AstraZeneca4
Bayer4
Bristol-Myers Squibb3
Memorial Sloan Kettering Cancer Center3
National Medical Research Council (NMRC), Singapore3
Bracco Diagnostics, Inc2
Imunon2
Light Sciences Oncology2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms71
Carcinoma, Hepatocellular41
Neoplasms9
Bile Duct Neoplasms5
Carcinoma4
Colorectal Neoplasms4
Gallbladder Neoplasms4
Neoplasm Metastasis4
Pancreatic Neoplasms4
Agnosia3

Trials

Showing 76 to 71 of 71. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.